Vaccine Awareness and Education

19 Effectiveness of Johnson and Johnson vaccine One dose vaccine that was tested against three different strains of virus, later in time with much higher baseline COVID-19 incidence - Fall 2020. 93% protection against hospitalizations. Highly effective at preventing severe disease 85% against all strains of virus. Including moderate and severe disease: - - - South Africa; 57% (95% of cases were South Africa variant) United States: 72% Central & South America: 66% Effectiveness starts 2 weeks after the dose and has been studied up to 1 month after. There is evidence that antibody production continues to increase at least until day 56. Health -Authority

View entire presentation